The large tumor suppressor family: friend or foe?

Affiliations

¹ Department of Anatomical and Cellular Pathology, State Key Laboratory of Oncology in South China, State Key laboratory of Digestive Diseases, The Chinese University of Hong Kong, Hong Kong, China.

Editorial

Wei Kang et al. J Thorac Dis. 2017 Jul.

. 2017 Jul;9(7):1748-1751.

doi: 10.21037/jtd.2017.06.26.

¹ Department of Anatomical and Cellular Pathology, State Key Laboratory of Oncology in South China, State Key laboratory of Digestive Diseases, The Chinese University of Hong Kong, Hong Kong, China.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.
Moroishi T, Hayashi T, Pan WW, Fujita Y, Holt MV, Qin J, Carson DA, Guan KL. Moroishi T, et al. Cell. 2016 Dec 1;167(6):1525-1539.e17. doi: 10.1016/j.cell.2016.11.005. Cell. 2016. PMID: 27912060 Free PMC article.

1. Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer 2013;13:246-57. 10.1038/nrc3458 - DOI - PubMed
1. Johnson R, Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov 2014;13:63-79. 10.1038/nrd4161 - DOI - PMC - PubMed
1. Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer 2015;15:73-9. 10.1038/nrc3876 - DOI - PMC - PubMed
1. Yu FX, Zhao B, Guan KL. Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell 2015;163:811-28. 10.1016/j.cell.2015.10.044 - DOI - PMC - PubMed
1. Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev 2016;30:1-17. 10.1101/gad.274027.115 - DOI - PMC - PubMed